ABG Analytics logo
Get updates

Amgen Inc (NASDAQ: AMGN)

DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 07/02/2020
Closing price: 258.24
Support price level: $235.40
Resistance price level: N/A
Relative strength index (14-day RSI) 81.2
Beta 0.27
  • AMGN is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.

  • With a 36.9 percent return in the past year, this stock outperformed 90 percent of stocks in the S&P-100.

  • AMGN is one of this month's top performers with a return of 16.9 percent, beating 90 percent of stocks in the S&P-100.

  • Up 9.8 percent, AMGN is one of this week's biggest gainers.

  • The price of this low-beta stock is expected to increase by 0.27% for every 1% increase in the S&P-500.

  • Volatility is forecast to fall over the next month.

  • With RSI > 70, AMGN is overbought. Odds slightly favor a short-term price reversal.

  • Price broke above prior resistance level - a short-term bullish signal.

Low High Price as % of Range
$174.11 $258.24 100.0%
200 day 50 day 20 day 10 day
$221.50 $231.76 $231.65 $238.99
(Annualized standard deviation)
(5 year)
Last month Current estimate Next month forecast
26.4% 28.1% 39.0% 30.3%
There is an estimated 5% probability that the stock price of Amgen Inc will fall by more than:
  • 10.6% in the next week.

  • 17.1% in the next month.

  • 61.5% in the next year.